Protecting Your Patients from HPV: Reducing the Risk of Vaccine-Preventable HPV-related Cancers and Diseases

Protecting Your Patients from HPV: Reducing the Risk of Vaccine-Preventable  HPV-related Cancers and Diseases
Overview

Human papillomavirus (HPV) contributes to various types of cancers, such as cervical and anal cancers, as well as other types of diseases, including genital warts. HPV vaccination has been used for over 10 years globally and is highly protective against HPV infection. This program, narrated by pharmacist Parveen Gill, will help to provide pharmacists with background information related to HPV vaccines and offer recommendations for how to put their knowledge into practice. Pharmacists will learn about HPV-related diseases and complications and the effectiveness of the available HPV vaccines. Practical tips on identifying patients at risk of HPV and assessing their vaccine status will be provided in the presentation, as well as guidance for how to implement National Advisory Committee on Immunization (NACI) recommendations in pharmacy practice.  


Disclosures: The author has disclosed that she has been a member of an advisory board, and received funds from a commercial entity other than this one. The expert reviewer has no conflicts of interest to disclose.



This program has been supported by an educational grant from Merck Canada.


$0.00
1.00 CEU
 
Author

Parveen Gill
BSc (Pharm), APA, CDE, CTH, CAE

Reviewers

Carlene Oleksyn
BScPhm, CDE, CTH

1057-2018-2518-I-P
(Expires: 24-May-2019)